MedPath

NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD

πŸ‡ΈπŸ‡¬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Feasibility Study of Intraperitoneal Paclitaxel

Phase 2
Conditions
Gastric Cancer
Interventions
Drug: IP Paclitaxel
First Posted Date
2012-12-04
Last Posted Date
2016-06-07
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
20
Registration Number
NCT01739894
Locations
πŸ‡ΈπŸ‡¬

National University Hospital, Singapore, Singapore

Coffee and Metabolic Health Outcomes

Not Applicable
Completed
Conditions
Insulin Resistance
Interventions
Dietary Supplement: Coffee
Dietary Supplement: Placebo
First Posted Date
2012-11-30
Last Posted Date
2015-04-23
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
128
Registration Number
NCT01738399
Locations
πŸ‡ΈπŸ‡¬

Saw Swee Hock School of Public Health, Singapore, Singapore

Antibiotics for Klebsiella Liver Abscess Study

Phase 4
Completed
Conditions
Liver Abscess, Pyogenic
Interventions
Drug: Trimethoprim/sulfamethoxazole
First Posted Date
2012-11-07
Last Posted Date
2018-08-27
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
152
Registration Number
NCT01723150
Locations
πŸ‡ΈπŸ‡¬

National University Hospital, Singapore, Singapore

πŸ‡ΈπŸ‡¬

Singapore General Hospital, Singapore, Singapore

πŸ‡ΈπŸ‡¬

Tan Tock Seng Hospital, Singapore, Singapore

Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin

Not Applicable
Conditions
Infections Requiring Prolonged Duration (>10 Days) of Vancomycin
Interventions
First Posted Date
2012-11-02
Last Posted Date
2012-11-02
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
220
Registration Number
NCT01720940
Locations
πŸ‡ΈπŸ‡¬

National University Hospital, Singapore, Singapore

Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia

Conditions
Haematological Malignancies
Acquired Aplastic Anaemia
First Posted Date
2012-11-01
Last Posted Date
2013-12-11
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
21
Registration Number
NCT01719341
Locations
πŸ‡ΈπŸ‡¬

National University Hospital, Singapore, Singapore

Investigating the Effects of Exercise on Physiological Changes and Toxin Removal in Hemodialysis Patients

Not Applicable
Conditions
Renal Dialysis
Interventions
Procedure: Intra-dialytic exercise
First Posted Date
2012-08-28
Last Posted Date
2014-04-03
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
15
Registration Number
NCT01674153
Locations
πŸ‡ΈπŸ‡¬

Dialysis Center, National University of Singapore, Singapore, Singapore

Diagnosis of Lung Cancer From Exhaled Breath With Silicon Biophotonic Device

Not Applicable
Withdrawn
Conditions
Lung Cancer
First Posted Date
2012-08-08
Last Posted Date
2017-04-18
Lead Sponsor
National University Hospital, Singapore
Registration Number
NCT01660087
Locations
πŸ‡ΈπŸ‡¬

National University Hospital/ National University of Singapore, Singapore, Singapore

πŸ‡ΈπŸ‡¬

Institute of Microelectronics, Singapore, Singapore

Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD

Not Applicable
Conditions
Breast Carcinoma
Interventions
First Posted Date
2012-08-01
Last Posted Date
2016-06-22
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
110
Registration Number
NCT01655004
Locations
πŸ‡ΈπŸ‡¬

National University Hospital, Singapore, Singapore

Autologous Cord Blood Cells for Brain Injury in Term Newborns

Phase 1
Completed
Conditions
Hypoxic Ischemic Encephalopathy
Interventions
Biological: Autologous cord blood
First Posted Date
2012-07-25
Last Posted Date
2017-01-26
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
2
Registration Number
NCT01649648
Locations
πŸ‡ΈπŸ‡¬

National University Hospital, Singapore, Singapore

πŸ‡ΈπŸ‡¬

KK Women's and Children's Hospital, Singapore, Singapore

πŸ‡ΈπŸ‡¬

Singapore General Hospital, Singapore, Singapore

Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis

Phase 2
Conditions
Tuberculosis, Pulmonary
Interventions
Drug: Placebo
First Posted Date
2012-07-11
Last Posted Date
2017-04-04
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
32
Registration Number
NCT01638520
Locations
πŸ‡ΈπŸ‡¬

National University Hospital, Singapore, Singapore, Singapore

πŸ‡²πŸ‡Ύ

University Malaya Medical Centre, Kuala Lumpur, Malaysia

πŸ‡ΈπŸ‡¬

Changi General Hospital, Singapore, Singapore

and more 4 locations
Β© Copyright 2025. All Rights Reserved by MedPath